Neuroendocrine Cancer
12 clinical trials · Condition
| Record | Firm | Date |
|---|---|---|
| Phase II Study of Pembrolizumab and Lenvatinib in Advanced Well-differentiated Neuroendocrine Tumors (NCT03290079) | H. Lee Moffitt Cancer Center and Research Institute | 2017-12-15 |
| Carfilzomib for the Treatment of Patients With Advanced Neuroendocrine Cancers (NCT02318784) | SCRI Development Innovations, LLC | 2015-07-15 |
| Clinical Trial of the Impact of Treatment Consultation Recordings on Cancer Patient Outcomes (NCT01866228) | University of Manitoba | 2013-06-01 |
| Hyperthermia/Thermal Therapy With Chemotherapy to Treat Inoperable or Metastatic Tumors (NCT00178698) | The University of Texas Health Science Center, Houston | 2002-07-01 |
Track Neuroendocrine Cancer automatically
Every clearance here is in the API, with alerts when new ones post.